Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 August 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 187 pages)

 

Export 16 results:
Author Title Type [ Year(Asc)]
Filters: Author is Ernst, P.  [Clear All Filters]
2019
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
2018
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
2017
B. M. Hicks, Yin, H., Bladou, F., Ernst, P., and Azoulay, L., “Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia”, Thorax, vol. 72, pp. 596-597, 2017.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events”, Eur Respir J, vol. 49, 2017.
P. Brassard, Wu, J. W., Ernst, P., Dell'Aniello, S., Smiechowski, B., and Suissa, S., “The effect of statins on influenza-like illness morbidity and mortality”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 63-70, 2017.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study”, Chest, vol. 151, pp. 60-67, 2017.
J. Y. Shin, Eberg, M., Ernst, P., and Filion, K. B., “Statin potency and the risk of hospitalization for community-acquired pneumonia”, Br J Clin Pharmacol, vol. 83, pp. 1319-1327, 2017.
2016
K. B. Filion, Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., Hu, N., Paterson, J. M., Targownik, L., Turin, T. C., Udell, J. A., and Ernst, P., “A Multicenter Observational Study of Incretin-based Drugs and Heart Failure”, N Engl J Med, vol. 374, pp. 1145-54, 2016.
C. Renoux, Dell'Aniello, S., Khairy, P., Marras, C., Bugden, S., Turin, T. C., Blais, L., Tamim, H., Evans, C., Steele, R., Dormuth, C., and Ernst, P., “Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease”, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
2015
J. L. Faillie, Filion, K. B., Patenaude, V., Ernst, P., and Azoulay, L., “Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes”, Diabetes Obes Metab, vol. 17, pp. 379-85, 2015.
C. Renoux, Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J. P., Tamim, H., Mahmud, S. M., Alsabbagh, M. W., Hemmelgarn, B., Dormuth, C. R., and Ernst, P., “Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis”, Clin J Am Soc Nephrol, vol. 10, pp. 1716-22, 2015.
2014
K. B. Filion, Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., Teare, G. F., Ravani, P., Ernst, P., and Dormuth, C. R., “Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis”, Gut, vol. 63, pp. 552-8, 2014.
2013
C. R. Dormuth, Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., Lafrance, J. P., Levy, A., Garg, A. X., and Ernst, P., “Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases”, Bmj, vol. 346, p. f880, 2013.
2012
P. Ernst, Renoux, C., Dell'Aniello, S., and Suissa, S., “Pramipexole use and the risk of pneumonia”, BMC Neurol, vol. 12, p. 113, 2012.
2011
P. Ernst, Dell'Aniello, S., Mikaeloff, Y., and Suissa, S., “Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study”, BMC Pulm Med, vol. 11, p. 59, 2011.
2007
K. B. Filion, Delaney, J. A., Brophy, J. M., Ernst, P., and Suissa, S., “The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 16, pp. 1-4, 2007.
[Page last reviewed 5 August 2019]